A delegation from the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce (ACFIC) conducted an inspection tour in Zibo

On April 11, a 27-member delegation visited Zibo for inspection, led by Han Xu, Vice President of the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce (ACFIC) and Chairman of Realcan Pharmaceutical Group. The delegation included Yin Haifeng, Deputy Secretary-General and Director of the Membership Department; Chen Shuai, Executive Director of the Excipients and Packaging Materials Committee; Cheng Hui, Executive Director of the Pharmaceutical Equipment Committee; as well as representatives from leading excipient, packaging and pharmaceutical equipment enterprises. Sun Feng, Deputy Director of the Zibo United Front Work Department and Party Secretary of the Zibo Federation of Industry and Commerce, and Hu Yanxia, Vice Chairwoman of the Zibo Federation of Industry and Commerce, accompanied the delegation during the activities. Zheng Jiaqing, President of Zibo Pharmaceutical Industry Chamber of Commerce and Chairman of Qidu Pharmaceutical, attended the event and presided over the joint exchange meeting. The meeting was also attended by heads of some member companies and board units of the Zibo Pharmaceutical Industry Chamber of Commerce.

Accompanied by Xu Wenhui, General Manager of Xinhua Pharmaceutical, and Zheng Jiaqing, Chairman of Qidu Pharmaceutical, the delegation visited the Xinhua Pharmaceutical Exhibition Hall, R&D Center and International Cooperation Center. The delegation also toured Yongju Technology's Pharmaceutical Packaging Materials Industrial Park, Qidu Pharmaceutical's large-scale injectable production project with an annual capacity of 1 billion bottles/bags, and the company's research institute. After the tour, a joint exchange meeting between the Pharmaceutical Industry Chamber of Commerce of ACFIC and Zibo Pharmaceutical Industry Chamber of Commerce was held at Qidu Pharmaceutical. Chen Shuai and Cheng Hui respectively introduced the work of the Excipients and Packaging Materials Committee and the Pharmaceutical Equipment Committee. Zhang Jianyong, General Manager of Qidu Pharmaceutical, Zheng Xiaoning, General Manager of Yongju Technology, and Miao Qiyi, Technical Director of Xinma Pharmaceutical Equipment, presented their companies' developments. More than 30 enterprise representatives from both chambers exchanged views. During the meeting, representatives from Zibo's pharmaceutical enterprises, relevant leaders from Qidu Pharmaceutical and department heads conducted extensive, in-depth and enthusiastic discussions with representatives from non-local enterprises. Over 100 pieces of information were exchanged, resulting in more than 20 cooperation intentions. This event holds significant guiding importance for promoting resource sharing and industrial chain collaboration between Zibo's pharmaceutical enterprises and their counterparts from other regions.

Han Xu pointed out in his speech that the pharmaceutical industry has seen frequent policy changes in recent years and is now at a critical juncture of transformation and upgrading, bringing both opportunities and challenges. Facing the new situation, it is necessary to unite for mutual support, strengthen collaborative cooperation across the industrial chain, enhance enterprises' risk resilience, and ensure steady and long-term development. He stated that this exchange event has initiated a new phase of in-depth dialogue between the All-China Federation of Industry and Commerce Pharmaceutical Chamber and the Zibo Pharmaceutical Chamber, which will effectively promote regional coordinated development and contribute to building a national pharmaceutical industry ecosystem. He expressed hope that the Zibo Pharmaceutical Chamber and the All-China Federation of Industry and Commerce Pharmaceutical Chamber would establish a regular exchange mechanism to create more valuable opportunities for communication and cooperation between their member enterprises, enhance mutual exchanges, complement each other's strengths, and jointly write a magnificent chapter for China's pharmaceutical industry.

Yin Haifeng introduced the organizational structure and work development of the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce. He pointed out that the chamber is a national-level comprehensive platform for the pharmaceutical industry, committed to building a resource-sharing platform, a bridge for government-enterprise communication, and a highland for collaborative innovation in the pharmaceutical sector. Currently, the chamber has 1,500 direct member enterprises and 58 group members, with 11 specialized committees and 8 service platforms covering the entire pharmaceutical industry chain, capable of addressing issues encountered by enterprises throughout their production and operation processes. He expressed hope that member enterprises would make full use of the platform's resources to jointly foster a favorable ecosystem and promote high-quality development of the pharmaceutical industry. Yin Haifeng acknowledged Qidu Pharmaceutical's developmental achievements over the 27 years since its restructuring, commending its persistent efforts in increasing investment, launching projects, expanding scale, and adhering to the path of integrating industry, academia, and research, which have resulted in a hundredfold growth in economic indicators. He emphasized that Qidu Pharmaceutical possesses solid foundations and extensive experience in production capacity, R&D innovation, talent pool, process layout planning and design, as well as informatization and intelligentization, making it worthy of widespread promotion within the industry to lead and drive better and faster development of the pharmaceutical sector. In conclusion, he remarked that today's event was substantial in content and innovative in format, with member enterprises achieving fruitful results and gains. He suggested that the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce draw lessons from and replicate this conference's organizational model to deepen and solidify its services for member enterprises.

Hu Yanxia introduced Zibo's favorable business environment and the measures taken by the Federation of Industry and Commerce at all levels to serve enterprises as their "supportive family". She expressed welcome to enterprises nationwide to invest and establish businesses in Zibo, while also suggesting that private enterprises should standardize the establishment of modern enterprise systems, comprehensively strengthen compliance management, and achieve long-term stable and healthy development. She pointed out that this inspection tour organized by the All-China Federation of Industry and Commerce Pharmaceutical Chamber and Zibo Pharmaceutical Chamber was rich in content, practical and effective, with strong interaction. The particularly well-arranged in-depth on-site communication between Qidu Pharmaceutical, Zibo chamber enterprises and external enterprises achieved precise connection and efficient coordination among enterprises, which vividly demonstrated the role of the chamber as an industry exchange platform.

Zheng Jiaqing extended a warm welcome to the inspection delegation from the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce. He first introduced the basic situation of Zibo's pharmaceutical industry development, as well as the establishment and work progress of Zibo Pharmaceutical Industry Chamber of Commerce. He pointed out that Zibo is a major pharmaceutical city in China and an important drug production base, having formed a comprehensive industrial system with over 240 enterprises engaged in production, operation, R&D and services, maintaining a leading industrial scale in Shandong province for many years. Since its establishment in November 2024, Zibo Pharmaceutical Chamber has generated strong responses both socially and within the industry. The concept of "uniting to expand globally, compete in the market and build brands together" and the grand vision of "building Zibo into a strong pharmaceutical city and famous medicine hub while cultivating a 100-billion-level industrial cluster" have gained widespread consensus. The Chamber will fully leverage its role as a communication platform and bridge, uniting and leading member enterprises to ensure their stable and healthy development, earnestly implement the Chamber's annual key work plan, and make greater contributions to local economic and social development. He noted that over the past two decades since its establishment, the national Pharmaceutical Chamber has consistently adhered to its purpose of "serving member enterprises, promoting industry development, and contributing to human health", effectively fulfilling its bridging role between government and enterprises as well as between enterprises and the market, and has carried out substantial fruitful work that significantly contributed to the healthy development of China's pharmaceutical industry. He emphasized the hope to take this joint meeting as an opportunity to fully utilize the Chamber's platform functions, guide and support resource sharing among upstream and downstream enterprises, and actively promote the healthy development of member enterprises and the national pharmaceutical industry.